CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.
about
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progressionGlioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and RadioresistanceCXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targetingInsidious changes in stromal matrix fuel cancer progressionStroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesisTumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerTumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changesNF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy targetIntegrins in cancer: biological implications and therapeutic opportunitiesElucidating a key component of cancer metastasis: CXCL12 (SDF-1α) binding to CXCR4.Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer.Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study.Microenvironmental regulation of therapeutic response in cancerCXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment.Effect of biodegradability on CXCR4 antagonism, transfection efficacy and antimetastatic activity of polymeric PlerixaforGenes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4(+) T cells in human t cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinomaPrognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancerFibroblast heterogeneity in the cancer wound.Co-expression of uPAR and CXCR4 promotes tumor growth and metastasis in small cell lung cancer.Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas.Synthetic lethal screen of an EGFR-centered network to improve targeted therapies.New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrenceCXCL12 Modulates Prostate Cancer Cell Adhesion by Altering the Levels or Activities of β1-Containing Integrins.Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrowHypoxia promotes migration and induces CXCR4 expression via HIF-1α activation in human osteosarcoma.Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.Translational horizons in the tumor microenvironment: harnessing breakthroughs and targeting cures.The First Type III Domain of Fibronectin is Associated with the Expression of Cytokines within the Lung Tumor MicroenvironmentDifferential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms.Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells.Chemokine stimulation promotes enterocyte migration through laminin-specific integrins.Prognostic value of stromal cell-derived factor 1 expression in patients with gastric cancer after surgical resection.Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer.Integrin-mediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells.Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.Role of chemokines in tumor growth.The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis.Overcoming drug resistance and treating advanced prostate cancerCXC chemokine ligand 12/stromal cell-derived factor-1 regulates cell adhesion in human colon cancer cells by induction of intercellular adhesion molecule-1
P2860
Q24635943-151D1F75-1E2D-4FB1-93B9-D12D665E70E2Q26765869-E37E88DD-2813-4375-9C36-26A2D78A66E5Q26849606-57665564-375B-47DC-9AC4-B28CBC89E36FQ26851261-F311C29E-4C7E-421B-BD18-64BEC46F3C60Q28260997-239B22B1-5427-46E2-A77F-4FAC9698162FQ28396304-801DCA81-06F0-4E91-81FA-608B8333D204Q28539958-F2BC8D4A-D18C-4286-969A-1757A568DC0CQ28611413-B45FA430-5B64-4BE2-8D8F-15E9C5231CBCQ29614536-2FF72AB0-84CA-4EE0-B8A3-A5F121F984E2Q30577284-E38F98DF-9713-4A4D-A5A5-1A10238713ABQ33238496-75D3AFF5-B54A-4ED6-99E4-CDD8F7D0DDB9Q33639397-0C5435C8-5B3C-468A-96D7-285A75D1CC8CQ33654609-B23EB0D7-6603-49AF-B884-E1363F49980CQ33677057-D5500E29-71E2-4874-A4FC-48811092F142Q33687703-42AD2A59-A6CC-47BC-A2E9-B4D9729E5846Q33713794-F2FFB034-DEF3-4805-AD91-88276CA3A896Q33775283-D61C317A-51DD-413E-A0C3-38141EC769D4Q33915672-BBDD3A39-B28B-46CB-9000-8571E4618BD2Q33964324-32C39A02-A9AE-496B-920A-1BF68CCF8B12Q34028966-F14EB8F8-AB8C-44BA-BB72-0A9C59699587Q34146951-C7C5CBFB-182B-4A92-897B-E3AAAE48A660Q34175680-DF9F1AF2-0787-4394-9CFC-3D6CD8B78F18Q34382914-B84F1382-6FD2-4E1C-9FFF-3E63AFC638B2Q34786176-EAE48A53-28E3-440F-9D31-D9E60C109435Q34980277-2D1A6BB4-74B3-476A-B4C9-FA11FAA79774Q35117825-F7EDBB94-1441-42B5-89F1-BF2CABAAE5A1Q35213463-47BA0C7D-D866-4E3E-852D-B81E9A66B6F1Q35219539-1457D6AF-5378-4F98-964C-581216306352Q35278766-4DC1D5D7-8DE8-4F5A-8AC0-6E1E40055A21Q35550241-7704C089-7608-4EF0-8695-4C94EB41B727Q35573448-9D180BF3-F6C9-4D51-9AD2-AA41A9966ABAQ35601281-36AB522C-F894-4C26-86F5-6DE371C1353AQ35713406-E09EFB04-0A96-4A49-A7C1-51DEE5DE5966Q36011854-E1E14770-914D-4BB5-B3B8-4F48D233B4D0Q36015267-A3546242-EEFB-4AC4-BFDA-3DB941DA69C0Q36016645-0B7ADA5B-F26D-4843-9C1F-C18FE978CA88Q36120825-B1C91F6F-2F77-44A1-82A3-436B7FDF4A22Q36318564-008208B5-9484-47BD-A79D-ACCE99F71257Q36328812-3ECBE55F-4D93-4997-B1AB-E80EB572FEE0Q36369111-248CEDC0-F0A4-4BE7-9241-5718F5B5E230
P2860
CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
CXCR4 chemokine receptor and i ...... cell lung cancer (SCLC) cells.
@en
type
label
CXCR4 chemokine receptor and i ...... cell lung cancer (SCLC) cells.
@en
prefLabel
CXCR4 chemokine receptor and i ...... cell lung cancer (SCLC) cells.
@en
P2093
P2860
P356
P1433
P1476
CXCR4 chemokine receptor and i ...... cell lung cancer (SCLC) cells
@en
P2093
Aleksandra Glodek
Jan A Burger
Meike Burger
Nobutaka Fujii
P2860
P2888
P304
P356
10.1038/SJ.ONC.1208621
P407
P577
2005-06-01T00:00:00Z
P5875
P6179
1034594775